Tags: AAV, adeno-associated virus, gene therapy, genetics, methods and technology, next generation sequencinggeneticscryptoaavechain reaction
Profile | Contacts | Recent Articles on Subject | |
---|---|---|---|
1 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | Novartis gene therapy set to enhance SMA treatment - about 2 months ago Bug in the system - about 1 year ago | |
2 | Meagan Parrish Pharma Voice Senior editor @industrydive.
Pharma world follower. Wisconsin, USA | 4 companies to watch in the accelerating gene editing race - 2 months ago | |
3 | STAT Staff STAT News Frontiers of health & medicine reporting. | STAT stories you might have missed in 2024 - 2 months ago | |
4 | <em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. | New Frontiers in Vaccine Development - 3 months ago Quality Control for Cell and Gene Therapy - 8 months ago Bringing Gene Therapy to the Brain - 8 months ago | |
5 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | ||
6 | Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. | Bringing Gene Therapy to Age-Related Macular Degeneration - about 1 year ago | |
7 | Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile | 2024 PharmaVoice 100s: Cell and Gene Therapy Pioneers - 4 months ago One biotech’s 3 gene therapy hurdles: delivery, delivery and delivery - about 1 year ago A new delivery method muscling its way into the RNA space - over 1 year ago | |
8 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
9 | Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia | ||
10 | Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois |